Molecular Oncology
Overview
Molecular Oncology is a peer-reviewed journal that focuses on the molecular mechanisms underlying cancer development and progression. It publishes cutting-edge research articles, reviews, and commentaries, covering topics such as oncogenes, tumor suppressor genes, signaling pathways, biomarkers, and targeted therapies. With its interdisciplinary approach, Molecular Oncology serves as a valuable resource for researchers, clinicians, and students in the field of cancer biology and personalized medicine.
Details
Details
Abbr.
Mol Oncol
Start
2007
End
Continuing
Frequency
Six no. a year, 2009-
p-ISSN
1574-7891
e-ISSN
1878-0261
Country
United States
Language
English
Specialties
Oncology
Molecular Biology
Molecular Biology
Metrics
Metrics
h-index / Ranks: 2493
113
SJR / Ranks: 1246
1940
CiteScore / Ranks: 990
11.80
JIF / Ranks: 945
6.6
Recent Articles
11.
Valentini S, Mele G, Attili M, Assenza M, Saccoccia F, Sardina F, et al.
Mol Oncol
. 2025 Mar;
PMID: 40022459
Targeting the heterodimer MDM2/MDM4 is a novel and effective route for the reactivation of wild-type p53 in human tumors with reduced toxicity in nontransformed cells. To improve the therapeutic potential...
12.
Wu W, Wang J, Chen F, Wang X, Lan B, Fu R, et al.
Mol Oncol
. 2025 Feb;
PMID: 40018995
Hepatocellular carcinoma (HCC), the sixth most prevalent cancer globally, is characterized by high recurrence rates and poor prognosis. Investigating the heterogeneity of relapsed HCC and identifying key therapeutic targets may...
13.
Kim S, Kang M, Jeong S, Kim J, Kim K, Lee W, et al.
Mol Oncol
. 2025 Feb;
PMID: 40017120
Colorectal cancer (CRC) is widely recognized for its high prevalence and significant mortality rates, and purine metabolism has been serving as a potential therapeutic target. However, purine metabolism has not...
14.
Segeren H, Wierenga K, Riemers F, van Liere E, Westendorp B
Mol Oncol
. 2025 Feb;
PMID: 40009518
Oncogene-induced replication stress (RS) is a vulnerability of cancer cells that forces reliance on the intra-S-phase checkpoint to ensure faithful genome duplication. Inhibitors of the intra-S-phase checkpoint kinases ATR and...
15.
Latowska-Lysiak J, Zarebska Z, Sajek M, Grabowska A, Buratin A, Glodowicz P, et al.
Mol Oncol
. 2025 Feb;
PMID: 40008750
Glioblastoma (GBM) is the most aggressive and lethal type of glioma, characterized by aberrant expression of noncoding RNAs including circular RNAs (circRNAs). CircRNAs may impact cellular processes by interacting with...
16.
Thankan R, Thomas E, Weldemariam M, Purushottamachar P, Huang W, Kane M, et al.
Mol Oncol
. 2025 Feb;
PMID: 40007440
Cholesterol (CHOL) homeostasis is significantly modulated in prostate cancer (PCa) suggesting an active role in PCa development and progression. Several studies indicate a strong correlation between elevated CHOL levels and...
17.
Islam R, Roche M, Lin Z, Whitaker-Menezes D, Diaz-Barros V, Serrano E, et al.
Mol Oncol
. 2025 Feb;
PMID: 39996379
Chondrosarcomas are common bone sarcomas frequently resistant to radiation and chemotherapy, with high recurrence rates, development of metastatic disease, and death. Fibrosarcomas are soft tissue sarcomas associated with poor outcomes....
18.
Dive I, Hahnefeld L, Wenger K, Kogel D, Steinbach J, Geisslinger G, et al.
Mol Oncol
. 2025 Feb;
PMID: 39992790
Glioblastoma (GB) is the most aggressive primary brain tumor with poor prognosis despite multimodal therapy. Calorie-restricted diets have emerged as putative strategies to augment anticancer therapies. We employed UHPLC-high-resolution mass...
19.
Thery C, Louvard D
Mol Oncol
. 2025 Feb;
PMID: 39989268
Extracellular vesicles (EVs) have been studied for several decades and are attracting growing interest among life scientists and oncologists. Understanding the extent of diversity of their cellular origins, structure, molecular...
20.
Sharifi M, Feng E, Rydzewski N, Taylor A, Sperger J, Shi Y, et al.
Mol Oncol
. 2025 Feb;
PMID: 39985777
Metastatic castration-resistant prostate cancer (mCRPC) is a heterogeneous disease. Several studies have identified transcriptional subtypes of mCRPC, but comprehensive analysis of prognostic gene expression pathways has been limited. Therefore, we...